Management of a Patient With Metastatic Gastrointestinal Neuroendocrine Tumor and Meningioma Submitted to Peptide Receptor Radionuclide Therapy With 177 Lu-DOTATATE.

Pirisino, Riccardo; Filippi, Luca; D'Agostini, Antonio; Bagni, Oreste

Pirisino, Riccardo; Filippi, Luca; D'Agostini, Antonio; Bagni, Oreste.

Affiliation

Pirisino R; From the Department of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy.

Clin Nucl Med ; 47(11): e692-e695, 2022 11 01.

Article in En | MEDLINE | ID: mdl-35695716

Subject(s)

Intestinal Neoplasms; Meningeal Neoplasms; Meningioma; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Aged; Female; Humans; Lutetium; Meningeal Neoplasms/diagnostic imaging; Meningeal Neoplasms/radiotherapy; Meningioma/diagnostic imaging; Meningioma/radiotherapy; Neuroendocrine Tumors/pathology; Neuroendocrine Tumors/radiotherapy; Octreotide/therapeutic use; Organometallic Compounds/therapeutic use; Pancreatic Neoplasms/radiotherapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Peptide; Stomach Neoplasms

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Pancreatic Neoplasms / Neuroendocrine Tumors / Intestinal Neoplasms / Meningeal Neoplasms / Meningioma Limits: Aged / Female / Humans Language: En Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google